×
ADVERTISEMENT

VTE

Using AI to Predict VTE Risk in Cancer Pts

Artificial intelligence and machine learning could improve the ability to predict VTE in cancer patients over the ...

MAY 16, 2022

Apixaban Shows Advantage in Large Real-World Study of VTE Treatment in Cancer Patients

Orlando—Real-world data from more than 14,000 patients with active cancer and venous thromboembolism indicate ...

DECEMBER 8, 2019

DOACs Can Deliver for VTE in Patients With Cancer

With many providers turning to direct oral anticoagulants (DOACs) for treatment of venous thromboembolism (VTE) in ...

AUGUST 12, 2019

FDA Approves Bevyxxa for VTE

Patients hospitalized for an acute medical illness are at risk for thromboembolic complications due to moderate or ...

JUNE 27, 2017

Load more